IP Library Granted Patent US 9,120,607
Granted Patent B2
US 9,120,607 · App. 14/092,559 · Granted Sep 1, 2015

Sealable secondary packaging for pharmaceutical product blister pack

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,120,607
App. No.
14/092,559
Granted
Sep 1, 2015
Kind
B2
Abstract

A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).

Claims (34)

1. A pharmaceutical product supply, comprising:

a container comprising a first panel and a second panel that are disposed in spaced relation, an internal storage area between said first and second panels, a container opening that provides access to said internal storage area, and a closed container end opposite of said container opening, wherein an inner surface of said first panel defines a boundary of said internal storage area and comprises a first adhesive;

a first release liner disposed on said first adhesive, wherein said first release liner comprises a first release liner end and a second release liner end, wherein said first release liner utilizes a doubling-back configuration where said first release liner proceeds from said first release liner end of said first release liner toward said closed container end to a first location where said first release liner then proceeds back toward said container opening and terminates at said second release liner end of said first release liner, wherein a first portion of said first release liner extends between said first release liner end of said first release liner and said first location and is disposed over and contacts said first adhesive, and wherein a second portion of said first release liner extends between said first location and said second release liner end of said first release liner and is free from contact with said first adhesive;

a pharmaceutical product receiver disposed within said internal storage area and comprising a plurality of receptacles;

pharmaceutical product enclosed within at least one of said plurality of receptacles of said pharmaceutical product receiver;

a first configuration where said first portion of said first release liner remains on said first adhesive such that that said pharmaceutical product receiver is removable from said internal storage area of said container; and

a second configuration where said first release liner has been removed from said first adhesive by pulling on said second portion of said first release liner and where said pharmaceutical product receiver is thereafter bonded to said first panel within said internal storage area by said first adhesive.

2. The pharmaceutical product supply of claim 1 , wherein said second release liner end of said first release liner is a free end of said first release liner that is disposed proximate said container opening.

3. The pharmaceutical product supply of claim 2 , wherein said free end of said first release liner extends beyond said container opening so as to be disposed outside of said internal storage area.

4. The pharmaceutical product supply of claim 1 , wherein said first release liner end of said first release liner is located closer to said closed container end than said second release liner end of said first release liner.

5. The pharmaceutical product supply of claim 4 , wherein said second release liner end of said first release liner extends beyond said container opening such that it is disposed out of said internal storage area.

6. The pharmaceutical product supply of claim 5 , wherein said first release liner end of said first release liner is disposed within said internal storage area.

7. The pharmaceutical product supply of claim 4 , wherein an inner surface of said second panel defines a boundary of said internal storage area and comprises a second adhesive, wherein said pharmaceutical product supply further comprises a second release liner disposed on said second adhesive, wherein said second release liner comprises a first release liner end and a second release liner end, and wherein said second release liner utilizes a doubling-back configuration where said second release liner proceeds from said first release liner end of said second release liner toward said closed container end to a second location where said second release liner then proceeds back toward said container opening and terminates at said second release liner end of said second release liner, wherein a first portion of said second release liner extends between said first release liner end of said second release liner and said second location and is disposed over and contacts said second adhesive, and wherein a second portion of said second release liner extends between said second location and said second release liner end of said second release liner and is free from contact with said second adhesive.

8. The pharmaceutical product supply of claim 7 , wherein said second release liner end of said second release liner is a free end of said second release liner that is disposed proximate said container opening.

9. The pharmaceutical product supply of claim 8 , wherein said free end of said second release liner extends beyond said container opening so as to be disposed outside of said internal storage area.

10. The pharmaceutical product supply of claim 7 , wherein said first release liner end of said second release liner is located closer to said closed container end than said second release liner end of said second release liner.

11. The pharmaceutical product supply of claim 10 , wherein said second release liner end of said second release liner extends beyond said container opening such that it is disposed out of said internal storage area.

12. The pharmaceutical product supply of claim 11 , wherein said first release liner end of said second release liner is disposed within said internal storage area.

13. The pharmaceutical product supply of claim 7 , wherein said first configuration further comprises said first portion of said second release liner remaining on said second adhesive such that that said pharmaceutical product receiver is removable from said internal storage area of said container, and wherein said second configuration further comprises said second release liner having been removed from said second adhesive by pulling on said second portion of said second release liner and where said pharmaceutical product receiver is thereafter also bonded to said second panel within said internal storage area by said second adhesive.

14. The pharmaceutical product supply of claim 7 , further comprising:

a second pharmaceutical product receiver disposed within said internal storage area and comprising a plurality of receptacles; and

pharmaceutical product enclosed within at least one of said plurality of receptacles of said second pharmaceutical product receiver;

wherein said first configuration further comprises said first portion of said second release liner remaining on said second adhesive such that that said second pharmaceutical product receiver is removable from said internal storage area of said container, and wherein said second configuration further comprises said second release liner having been removed from said second adhesive by pulling on said second portion of said second release liner and where said second pharmaceutical product receiver is thereafter bonded to said second panel within said internal storage area by said second adhesive.

15. The pharmaceutical product supply of claim 1 , wherein an inner surface of said second panel defines a boundary of said internal storage area and comprises a second adhesive, wherein said pharmaceutical product supply further comprises a second release liner disposed on said second adhesive, wherein said second release liner comprises a first release liner end and a second release liner end, and wherein said second release liner utilizes a doubling-back configuration where said second release liner proceeds from said first release liner end of said second release liner toward said closed container end to a second location where said second release liner then proceeds back toward said container opening and terminates at said second release liner end of said second release liner, wherein a first portion of said second release liner extends between said first release liner end of said second release liner and said second location and is disposed over and contacts said second adhesive, and wherein a second portion of said second release liner extends between said second location and said second release liner end of said second release liner and is free from contact with said second adhesive.

16. The pharmaceutical product supply of claim 15 , wherein said second release liner end of said second release liner is a free end of said second release liner that is disposed proximate said container opening.

17. The pharmaceutical product supply of claim 16 , wherein said free end of said second release liner extends beyond said container opening so as to be disposed outside of said internal storage area.

18. The pharmaceutical product supply of claim 15 , wherein said first release liner end of said second release liner is located closer to said closed container end than said second release liner end of said second release liner.

19. The pharmaceutical product supply of claim 18 , wherein said second release liner end of said second release liner extends beyond said container opening such that it is disposed out of said internal storage area.

20. The pharmaceutical product supply of claim 19 , wherein said first release liner end of said second release liner is disposed within said internal storage area.

21. The pharmaceutical product supply of claim 15 , wherein said first configuration further comprises said first portion of said second release liner remaining on said second adhesive such that that said pharmaceutical product receiver is removable from said internal storage area of said container, and wherein said second configuration further comprises said second release liner having been removed from said second adhesive by pulling on said second portion of said second release liner and where said pharmaceutical product receiver is thereafter also bonded to said second panel within said internal storage area by said second adhesive.

22. The pharmaceutical product supply of claim 15 , further comprising:

a second pharmaceutical product receiver disposed within said internal storage area and comprising a plurality of receptacles; and

pharmaceutical product enclosed within at least one of said plurality of receptacles of said second pharmaceutical product receiver;

wherein said first configuration further comprises said first portion of said second release liner remaining on said second adhesive such that that said second pharmaceutical product receiver is removable from said internal storage area of said container, and wherein said second configuration further comprises said second release liner having been removed from said second adhesive by pulling on said second portion of said second release liner and where said second pharmaceutical product receiver is thereafter bonded to said second panel within said internal storage area by said second adhesive.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 31, 2025
From: SPECGX LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072313/0063 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: MALLINCKRODT LLC
To: SPECGX LLC
Reel/Frame 044891/0376 →